Cellectis S.A.
NASDAQ:CLLS · NASDAQ Global Market
-$0.02 today
Vol 0.16M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+106.94%
Period High
$5.35
Period Low
$1.44
Latest
$2.98
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$867.13M
Alto Neuroscience, Inc.
NYSE:ANRO
$783.30M
DBV Technologies S.A.
NASDAQ:DBVT
$382.75M
Amarin Corporation plc
NASDAQ:AMRN
$333.20M
Silence Therapeutics plc
NASDAQ:SLN
$327.10M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$305.94M
AC Immune S.A.
NASDAQ:ACIU
$241.71M
Korro Bio, Inc.
NASDAQ:KRRO
$128.40M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.32M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.02M
What is the latest CLLS filing?
The latest filing shown is 6-K dated Jun 11, 2026.
How many recent filings does CLLS have?
Intrinsic Alpha currently shows 20 recent filings for CLLS.
Explore More
Continue the stock analysis
Jump to another research area for this company.